According to Spectrum Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$61.89 M. In 2022 the company made an earning of -$71.89 M an increase over its 2021 earnings that were of -$0.15 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$61.89 M | -13.91% |
2022 | -$71.89 M | -51.33% |
2021 | -$0.15 B | -12.98% |
2020 | -$0.17 B | 20.64% |
2019 | -$0.15 B | 24.65% |
2018 | -$0.12 B | 12.11% |
2017 | -$0.11 B | 64% |
2016 | -$61.39 M | 48.62% |
2015 | -$41.31 M | 18.19% |
2014 | -$34.95 M | -0.56% |
2013 | -$35.15 M | -260.14% |
2012 | $21.94 M | -60.19% |
2011 | $55.13 M | |
2009 | -$28.51 M | 97.01% |
2008 | -$14.47 M | -61.1% |
2007 | -$37.2 M | 188.76% |
2006 | -$12.89 M | -35.34% |
2005 | -$19.93 M | 55.64% |
2004 | -$12.8 M | 24.21% |
2003 | -$10.31 M | -28.72% |
2002 | -$14.46 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | -27,526.84% | ๐บ๐ธ USA |
Novartis NVS | $9.43 B | -15,351.85% | ๐จ๐ญ Switzerland |
Pfizer PFE | $3.26 B | -5,379.49% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $6.66 B | -10,869.06% | ๐บ๐ธ USA |
Biogen BIIB | $1.29 B | -2,195.64% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $8.44 B | -13,739.08% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $7.53 B | -12,276.63% | ๐ฌ๐ง UK |
Seagen
SGEN | -$0.8 B | 1,177.57% | ๐บ๐ธ USA |
Curis CRIS | -$43.93 M | -29.01% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $0.40 B | -754.48% | ๐ฎ๐ฑ Israel |